Structural and functional echocardiographic characterisation and prognostic determinants in real-world transthyretin amyloid cardiomyopathy patients on standard of care
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognised as a significant cause of heart failure, particularly in elderly populations. Disease-modifying therapies, notably tafamidis, have altered the clinical landscape, yet real-world data on echocardiographic evolution and prognostic markers und...